Antonella Sgarbossa
Scuola Normale Superiore, National Enterprise for NanoScience and NanoTechnology
Papers
2
Total Citations
72
H-Index
2
About
Antonella Sgarbossa is a leading researcher in biophotonics and antimicrobial photodynamic therapy (aPDT), with a focused expertise in combatting *Helicobacter pylori* infections. Her major contributions center on understanding and exploiting the endogenous porphyrins produced by *H. pylori* for non-pharmacological treatment. In her highly cited 2017 work (43 citations), she pioneered the spectroscopic characterization and fluorescence imaging of these bacterial porphyrins, establishing a foundation for light-based diagnostics. Building on this, her 2020 study (29 citations) demonstrated the effective in vitro photoinactivation of *H. pylori* using a novel LED-based device, directly addressing the global crisis of antibiotic resistance—a primary driver of treatment failure in gastric diseases, including cancer. Sgarbossa’s work is notable for bridging fundamental photophysics with translational medical devices, offering a promising alternative to conventional antibiotics. Her research has significant implications for gastroenterology and infectious disease, positioning her as a key innovator in the fight against drug-resistant pathogens through light-based therapies.
Research Focus
Key Achievements
Top Papers
- 1
- 2